Start-up
CORAT Therapeutics GmbH
About CORAT Therapeutics
CORAT Therapeutics GmbH is based in Braunschweig, Germany. It is is a subsidiary of YUMAB GmbH and was founded with the support of the State of Lower Saxony and private investors. Using phage display, CORAT develops fully human antibodies as passive vaccines for the treatment and protection against infectious diseases.
- Founding: 2020
- Focus : Manufacturer
- Industry : Biotechnology, Pharma
Product portfolio of CORAT Therapeutics
News about CORAT Therapeutics
Here you will find CORAT Therapeutics GmbH
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
